Immunocore Holdings (IMCR) Liabilities and Shareholders Equity (2019 - 2026)
Immunocore Holdings (IMCR) posted Liabilities and Shareholders Equity of $1.12 billion for Q2 2026, up 3.4% from $1.08 billion a year earlier and up 4.4% from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Immunocore Holdings' Liabilities and Shareholders Equity came in at $1.07 billion, up 5.7% from FY2024.
- Annual Liabilities and Shareholders Equity has increased for six consecutive years, with a five-year compound annual growth rate of 32.6% (FY2020 to FY2025).
- In prior years, Immunocore Holdings' Liabilities and Shareholders Equity was $1.01 billion in FY2024 (+69.1%), $597 million in FY2023 (+16.9%), $510.83 million in FY2022 (+23.0%) and $415.2 million in FY2021 (+59.5%).
- The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2019.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last seven quarters, with growth averaging 13.3% over the last seven quarters.
- Across the past five years, year-over-year growth in Liabilities and Shareholders Equity ran from 1.6% in Q3 2025 to 85.7% in Q2 2024.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $1.07 billion (Q1 2026), $1.07 billion (Q4 2025) and $1.1 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Immunocore Holdings | 1.56 Bn | -1.92 Bn | 114.84 Mn | 1.12 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Bn |
| Mar 31, 2026 | 1.07 Bn |
| Dec 31, 2025 | 1.07 Bn |
| Sep 30, 2025 | 1.10 Bn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.01 Bn |
| Sep 30, 2024 | 1.08 Bn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 993.99 Mn |
| Dec 31, 2023 | 597.00 Mn |
| Jun 30, 2023 | 551.05 Mn |
| Dec 31, 2022 | 510.83 Mn |
| Sep 30, 2022 | 524.07 Mn |
| Dec 31, 2021 | 406.79 Mn |
| Dec 31, 2020 | 260.39 Mn |
| Dec 31, 2019 | 238.69 Mn |
API Access
Immunocore Holdings Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();